Evidence map›Paper›PMID 21160414›Full record

ArticleAIDS (London, England)2011

Eradication of HIV from the brain: reasons for pause.

Avindra Nath, Janice E Clements

Abstract readEditorial
In one paragraph

Article in AIDS (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  7. Article
  8. The role of human dopamine transporter in NeuroAIDS.Pharmacology & therapeutics · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. The effects of cocaine on HIV transcription.Journal of neurovirology · 2016
    Review
  13. Review
  14. Article
  15. Review
  16. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Avindra Nath
Janice E Clements

Funding

Neuropathogenesis of Retroviral InfectionsZIANS003130 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NATH, AVINDRA · 2011 to 2025
$73.7M
Role of HIV Tat protein in pathogenesis of HIV dementiaR01NS039253 · NINDS · UNIVERSITY OF KENTUCKY · PI SCHNAAR, RONALD L · 1999 to 2014
$4.5M
SSRI-neuroprotection for HIV/drug abuseR01DA024593 · NIDA · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2008 to 2012
$1.8M
Neuropathogenesis of Immune Reconstitution Syndrome with HIV InfectionR01NS056884 · NINDS · JOHNS HOPKINS UNIVERSITY · PI NATH, AVINDRA · 2006 to 2010
$1.7M
Role of CNS Opportunistic Infections in Subsequent Development of HIV EncephalitiR01NS055628 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PARDO-VILLAMIZAR, CARLOS A · 2008 to 2012
$1.6M
Intramural NIH HHS ZIA NS003130NIDA NIH HHS R01 DA024593NINDS NIH HHS R01 NS039253NINDS NIH HHS R01 NS055628NINDS NIH HHS R01 NS056884
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiretroviral Therapy, Highly ActiveBrainCD4-Positive T-LymphocytesHIV-1HIV InfectionsHumansVirus LatencyVirus Replication

Identifiers

PMID21160414
PMCPMC3681810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.